BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1648833)

  • 1. Alterations of cellular proteins in human cytomegalovirus infection: potential for disease pathogenesis.
    Grundy JE
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):38-41; discussion 41-2. PubMed ID: 1648833
    [No Abstract]   [Full Text] [Related]  

  • 2. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens.
    Beck S; Barrell BG
    Nature; 1988 Jan; 331(6153):269-72. PubMed ID: 2827039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and cellular effects of human cytomegalovirus infection.
    Albrecht T; Fons MP; Boldogh I; AbuBakar S; Deng CZ; Millinoff D
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):48-54, discussion 54-5. PubMed ID: 1648835
    [No Abstract]   [Full Text] [Related]  

  • 4. MHC gene in cytomegalovirus.
    Wiley D
    Nature; 1988 Jan; 331(6153):209-10. PubMed ID: 2827035
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus infection amplifies class I major histocompatibility complex expression on cultured human endothelial cells.
    Tuder RM; Weinberg A; Panajotopoulos N; Kalil J
    J Heart Lung Transplant; 1994; 13(1 Pt 1):129-38. PubMed ID: 8167118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and identification of HLA-A*1101 tetramer loading with human cytomegalovirus pp65 antigen peptide.
    Li F; Xu L; Zha Q; Chi X; Jia Q; He X
    Cell Mol Immunol; 2007 Apr; 4(2):141-6. PubMed ID: 17484809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression.
    Cinatl J; Vogel JU; Kotchetkov R; Wilhelm Doerr H
    FEMS Microbiol Rev; 2004 Feb; 28(1):59-77. PubMed ID: 14975530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
    Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
    Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus enhances PBMC binding and HLA class I expression on cultured endothelial cells.
    Tuder RM; Weinberg A; Panajotopoulos N; Kalil J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):91-2. PubMed ID: 1846720
    [No Abstract]   [Full Text] [Related]  

  • 10. Low multiplicity cytomegalovirus infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology.
    Arkonac B; Mauck KA; Chou S; Hosenpud JD
    J Heart Lung Transplant; 1997 Oct; 16(10):1035-45. PubMed ID: 9361246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US28 actions in HCMV infection: lessons from a versatile hijacker.
    Boomker JM; van Luyn MJ; The TH; de Leij LF; Harmsen MC
    Rev Med Virol; 2005; 15(4):269-82. PubMed ID: 15861487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of beta 2-microglobulin in cytomegalovirus infection.
    Grundy JE
    Scand J Rheumatol Suppl; 1990; 87():98-101; discussion 101. PubMed ID: 2175452
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of HLA expression in human cytomegalovirus immune evasion.
    Lin A; Xu H; Yan W
    Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin.
    Browne H; Smith G; Beck S; Minson T
    Nature; 1990 Oct; 347(6295):770-2. PubMed ID: 2172831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the human class I histocompatibility antigen, HLA-A2.
    Bjorkman PJ; Saper MA; Samraoui B; Bennett WS; Strominger JL; Wiley DC
    Nature; 1987 Oct 8-14; 329(6139):506-12. PubMed ID: 3309677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of CMV-associated diseases in 1990.
    Zaia JA
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):1-4. PubMed ID: 1648808
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.
    Cerboni C; Achour A; Wärnmark A; Mousavi-Jazi M; Sandalova T; Hsu ML; Cosman D; Kärre K; Carbone E
    Eur J Immunol; 2006 Mar; 36(3):732-41. PubMed ID: 16479538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
    Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
    J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial beta-2 microglobulin measurement as an auxilliary method in the early diagnosis of cytomegalovirus infection in renal transplant patients.
    Matos AC; Durão MS; Pacheco-Silva A
    Transplant Proc; 2004 May; 36(4):894-5. PubMed ID: 15194307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.